MiddleBrook to Webcast Management Presentation at the 10th Annual Rodman & Renshaw Healthcare Conference
October 14 2008 - 7:30AM
PR Newswire (US)
GERMANTOWN, Md., Oct. 14 /PRNewswire-FirstCall/ -- MiddleBrook
Pharmaceuticals, Inc. (NASDAQ:MBRK), a pharmaceutical company
focused on developing and commercializing novel anti-infective
products, today announced that MiddleBrook President and CEO John
Thievon will be presenting at the Rodman & Renshaw 10th Annual
Healthcare Conference at the New York Palace Hotel in New York City
on Nov. 11, 2008, at 12:00 p.m. (ET). A live audio webcast of the
presentation can be accessed by going to the Events section of
MiddleBrook's Investor Relations web site at
http://ir.middlebrookpharma.com/. A replay of the webcast will be
available later that day. About Middlebrook Pharmaceuticals:
MiddleBrook Pharmaceuticals, Inc. (NASDAQ:MBRK) is a pharmaceutical
company focused on the development and commercialization of
anti-infective drug products that fulfill substantial unmet medical
needs in the treatment of infectious disease. The Company is
developing anti-infective drugs based on its novel biological
finding that bacteria exposed to antibiotics in pulses are killed
more efficiently than those under standard treatment regimens.
Based on this finding, MiddleBrook has developed a proprietary,
once-a-day pulsatile delivery technology called PULSYS(R). The
Company currently markets the Keflex(R) brand of cephalexin and has
received regulatory approval for MOXATAG(TM) - the first and only
once-daily amoxicillin product approved for marketing in the U.S.
For more information on MiddleBrook, please visit
http://www.middlebrookpharma.com/. DATASOURCE: MiddleBrook
Pharmaceuticals, Inc. CONTACT: Faith Pomeroy-Ward of MiddleBrook
Pharmaceuticals, Inc., +1-301-944-6585 Web Site:
http://ir.middlebrookpharma.com/ http://www.middlebrookpharma.com/
Copyright
Middlebrook Pharmaceuticals (MM) (NASDAQ:MBRK)
Historical Stock Chart
From Jul 2024 to Aug 2024
Middlebrook Pharmaceuticals (MM) (NASDAQ:MBRK)
Historical Stock Chart
From Aug 2023 to Aug 2024